**Core tip:** Plexiform fibromyxoma (PF) is a very rare gastric submucosal tumor. Therefore, difficulties are associated with diagnosing PF preoperatively, particularly in a differential diagnosis of gastrointestinal stromal tumors with cystic changes. We suggest that the chronological changes observed by endoscopic ultrasound contribute to the preoperative diagnosis of PF. Furthermore, endoscopic submucosal dissection needs to be considered for the diagnostic treatment of PF without muscle invasion.

INTRODUCTION
============

Plexiform fibromyxoma (PF), also known as a plexiform angiomyxoid myofibroblastic tumor (PAMT), is a very rare gastric submucosal tumor (SMT) with a unique plexiform growth pattern of bland spindle cells\[[@B1]-[@B3]\]. Few studies have described the endoscopic ultrasound (EUS) characteristics of PF, and its chronological changes also remain unclear. We herein report a case of PF resected by endoscopic submucosal dissection (ESD) after a 4-year follow-up period.

CASE REPORT
===========

A 66-year-old man was referred to our institute for the management of a gastric tumor. An endoscopic examination revealed a SMT, approximately 20 mm in diameter, located in the antrum (Figure [1A](#F1){ref-type="fig"}). EUS showed an iso/hypoechoic mass in the third layer (Figure [1B](#F1){ref-type="fig"}). Computed tomography (CT) displayed a poorly enhanced lesion (Figure [2](#F2){ref-type="fig"}). Endoscopic biopsy and endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) were performed. Histological findings showed no malignant cells, and no further diagnosis was made.

![Endoscopic and endoscopic ultrasound findings. A: A submucosal tumor covered with a normal mucosa; B: An iso/hypoechoic mass with cystic components in the third layer; C, D: One year later; E, F: Four years later. The tumor increased in size and became pedunculated. Solid and multicystic parts both grew larger without muscle invasion.](WJGO-9-263-g001){#F1}

![Computed tomography of the patient. A computed tomography scan revealed a poorly enhanced tumor in the antrum.](WJGO-9-263-g002){#F2}

Yearly follow-up endoscopy revealed the slow growth of the tumor, which became pedunculated and showed transpyloric prolapse (Figures [1C](#F1){ref-type="fig"}-F). EUS revealed gradual increases in the solid and multicystic components without muscle invasion. Based on these findings, our preoperative diagnosis was a hamartomatous inverted polyp\[[@B4]-[@B6]\]. In order to avoid outlet obstruction and reach a histological diagnosis, ESD was performed (Figure [3](#F3){ref-type="fig"}).

![Endoscopic submucosal dissection. A: Tumor prolapse into the duodenum from the pylorus; B: Circumferential marking around the mass; C: Resected tumor retrieved using a snare; D: The ulcer bed after endoscopic submucosal dissection.](WJGO-9-263-g003){#F3}

On dissection, a glistening, 40 mm × 30 mm tumor covered with normal gastric mucosa was identified. Microscopically, the lesion showed a multinodular plexiform growth pattern, and consisted of bland spindle cells separated by abundant intercellular myxoid or fibromyxoid matrix. The stroma was rich in small vessels (Figure [4](#F4){ref-type="fig"}). Immunohistochemical tests revealed that tumor cells were focally positive for smooth muscle actin (SMA), muscle-specific actin (HHF35), and calponin, but were negative for c-kit, CD34, DOG-1, desmin, the S-100 protein, CD10, and h-caldesmon. The Ki-67 labeling index was approximately 2% (Figure [5](#F5){ref-type="fig"}). The pathological assessment led to a diagnosis of PF. Resected margins were histologically tumor-free. Although vascular invasion was positive, the patient did not undergo surgery due to the reportedly good prognosis of PF\[[@B1],[@B7]\], and remained under careful observation by endoscopy and CT follow-up. There was no recurrence or metastasis in the 12-mo follow-up.

![Histological appearance of the tumor. The margins were histologically tumor-free. A: The tumor showed a plexiform growth pattern; B, C: The tumor consisted of spindle-shaped cells with an abundant myxoid or fibromyxoid stroma; D: Some tumor cells intruded into the vessel space.](WJGO-9-263-g004){#F4}

![Hematoxylin and eosin. A: Histological appearance with hematoxylin and eosin (HE) staining; B-L: Immunohistochemically, tumor cells were focally positive for SMA (B), HHF35 (C), and calponin (D), but negative for c-kit (E), CD34 (F), DOG-1 (G), desmin (H), the S-100 protein (I), CD10 (K), and h-caldesmon (L); M: The Ki-67 labeling index was 2% at most.](WJGO-9-263-g005){#F5}

DISCUSSION
==========

Gastric PF is a new benign mesenchymal tumor that has been adopted by the 2010 WHO classification of tumors of digestive system\[[@B8]\]. The term PAMT is also used for this type of tumor. The distinction between these terms has been controversial\[[@B7],[@B9]\]. Previous studies reported that most cases of this tumor are found in the antrum, with approximately half extending into the extragastric soft tissues or proximal duodenum\[[@B2],[@B7]\]. The diagnosis of PF is based on its histological features, including immunohistochemical findings\[[@B1]\]. Its histology indicates a plexiform growth pattern composed of spindle cells, fine small vessels, and a myxoid matrix. Tumor cells are typically immunoreactive for SMA and HHF35, whereas c-kit, CD34, DOG-1, and the S-100 protein are nearly completely negative. Focal immunoreactivity for CD10, caldesmon, or desmin has occasionally been detected\[[@B1],[@B3],[@B7]\].

In the present case, endoscopy and EUS showed that the tumor grew gradually, with increases in the solid and multicystic components. Spindle cells, with a rich vascular myxoid stroma, were considered to be detected as an isoechoic lesion and fluid leakage was observed as a hypoechoic lesion.

Previous studies reported the lack of recurrence or metastasis of PF after excision\[[@B1],[@B7]\]; however, Miettinen et al\[[@B1]\] demonstrated that some plexiform elements showed intravascular involvement, suggesting that PF occasionally spreads through vessels. Since our case also exhibited vascular invasion, follow-up examinations were carefully performed. Since no patients have developed recurrence, annual endoscopy and CT are considered to be sufficient to monitor patients.

Although PF is considered to be benign, distal or partial gastrectomy is generally performed under the assumption of the presence of GIST\[[@B7]\]. Although GIST typically appears as a solid mass, few studies have described myxoid GIST that also shows a plexiform growth pattern\[[@B10]\], and some cases of GIST have shown cystic changes as a result of degeneration or necrosis\[[@B11]-[@B13]\]. Thus, it may be difficult to distinguish PF from these GIST by performing EUS only once. The chronological changes observed in the present case may contribute to a preoperative diagnosis of PF and the elucidation of its growth process. In this case, even though contrast-enhanced EUS was not performed, it may also be useful for reaching a differential diagnosis\[[@B14],[@B15]\]. The distinction of PF from a hamartomatous inverted polyp is also important. EUS-FNA is the first choice for a definite diagnosis of SMT\[[@B16]\]. Nevertheless, ESD remains an important option for diagnostic treatment, including that for cases of gastric SMT of the submucosal layer\[[@B6],[@B17]\]. Since EUS-FNA revealed no abnormalities in the present case, ESD was selected as a second choice. We performed *en bloc* ESD, which allowed for the diagnosis of PF. To the best of our knowledge, this is the first case report to describe the successful resection of PF by ESD. Further studies are needed in order to establish the appropriateness of ESD for PF.

COMMENTS
========

Case characteristics
--------------------

A 66-year-old man presented with a gastric tumor located in the antrum.

Clinical diagnosis
------------------

Gastric submucosal tumor.

Differential diagnosis
----------------------

A hamartomatous inverted polyp, myxoid gastrointestinal stromal tumor (GIST), and GIST with cystic degeneration.

Laboratory diagnosis
--------------------

Laboratory test results were within normal limits.

Imaging diagnosis
-----------------

Endoscopic ultrasound revealed an iso/hypoechoic mass of 20 mm in diameter in the third layer, and it showed gradual increases in the solid and multicystic components without muscle invasion.

Pathological diagnosis
----------------------

Plexiform fibromyxoma.

Treatment
---------

Endoscopic submucosal dissection was performed as a diagnostic treatment.

Related reports
---------------

Few studies have described plexiform fibromyxoma, also known as a plexiform angiomyxoid myofibroblastic tumor. Patients with plexiform fibromyxoma have generally undergone distal or partial gastrectomy.

Term explanation
----------------

Plexiform fibromyxoma is a new mesenchymal tumor entity that shows a unique plexiform growth pattern of bland spindle cells.

Experiences and lessons
-----------------------

Plexiform fibromyxoma needs to be considered in a differential diagnosis of gastric submucosal tumors, and follow-up endoscopic ultrasound (EUS) may be able to distinguish plexiform fibromyxoma from other gastric submucosal tumors.

Peer-review
-----------

The rarity of the case could be enriched with a brief review of the literature, due to the scarce number of papers reporting similar tumors. Moreover it could be interesting to expand data about EUS, for example explaining the characteristics of elastometry and eventual contrast enhancement. The quality of the article is augmented by the images, which are impressive and clear. Overall it is a good paper.

Institutional review board statement: This case report was exempt from approval by the Ethics Committee of Kobe University Hospital.

Informed consent statement: Informed consent was obtained from the patient.

Conflict-of-interest statement: The authors declare that they have no conflicts of interest.

Manuscript source: Invited manuscript

Specialty type: Gastroenterology and hepatology

Country of origin: Japan

Peer-review report classification

Grade A (Excellent): 0

Grade B (Very good): B

Grade C (Good): C

Grade D (Fair): 0

Grade E (Poor): 0

Peer-review started: October 25, 2016

First decision: March 8, 2017

Article in press: May 5, 2017

P- Reviewer: de\'Angelis GL, Meng ZQ S- Editor: Song XX L- Editor: A E- Editor: Lu YJ

[^1]: Author contributions: Kawara F, Tanaka S and Morita Y performed endoscopic resection and wrote the manuscript; Kawara F, Ohara Y and Okabe Y performed follow-up endoscopy and endoscopic ultrasound; Yamasaki T, Yokozaki H and Hirose T performed histopathological examinations; Hoshi N, Toyonaga T, Umegaki E and Azuma T contributed to the literature review and manuscript editing.

    Correspondence to: Fumiaki Kawara, MD, PhD, Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Hyogo, Japan. <lankey11@med.kobe-u.ac.jp>

    Telephone: +81-78-3826305 Fax: +81-78-3826309
